CLDI

Calidi Biotherapeutics, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Camaisa AllanDirector
$1.2k850 shares
SellDec 12, 2025
$1.46
--
Leftwich ScottDirector
$250k125k shares
BuyAug 21, 2025
$2.00
--
Schoeneck James ADirector
$150k75k shares
BuyAug 21, 2025
$2.00
--
Poma Eric EDirector, Officer: Chief Executive Officer
$50k25k shares
BuyAug 21, 2025
$2.00
--
Jackson Andrew C.Chief Financial Officer
$5.0k2.5k shares
BuyAug 21, 2025
$2.00
--
Camaisa AllanDirector, Officer: CEO And Chairman Of The Board
$16k10k shares
SellDec 17, 2024
$1.62
--

News

globenewswire.comCalidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Studyglobenewswire.comJun 16globenewswire.comCalidi Biotherapeutics Announces Investor Webinar on June 9, 2026globenewswire.comJun 8globenewswire.comCalidi Biotherapeutics Announces Online Abstract Acceptances at the 2026 ASCO Annual Meetingglobenewswire.comMay 26globenewswire.comCalidi Biotherapeutics Provides Required NYSE American Disclosureglobenewswire.comMay 22globenewswire.comCalidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlightsglobenewswire.comMay 14